Baudax Bio expects to raise $6.2 million from a public stock offering later this week.
The Malvern pharmaceutical company is selling slightly more than 11.8 million shares of its common stock, together with accompanying common stock purchase warrants, for 52.5 cents per share.
The warrants have an exercise price of the same 52.5 cents per share. The sale is expected to close on Thursday.
Baudax Bio's (NASDAQ: BXRX) stock opened Tuesday down 40% at 33 cents per share.
The company, according to…
